Amferia
Gothenburg, SE · 2 known investors
Amferia develops antimicrobial hydrogel wound dressings that kill bacteria including antibiotic-resistant strains using peptides bonded to hydrogel, for human and veterinary wound care applications. The company's patented technology creates a new class of medical device approved by the FDA for advanced wound management.
Founders & leadership
AK
Anand Kumar RajasekharaninPhD, CEO & Co-founder
SA
Saba AtefyektaPhD, Sales & Marketing Director & Co-founder
MA
Martin AnderssonPhD, R&D Director & Co-founder
Investors · 2
In the news
Frequently asked questions
- What does Amferia do?
- Amferia develops antimicrobial hydrogel wound dressings that kill bacteria including antibiotic-resistant strains using peptides bonded to hydrogel, for human and veterinary wound care applications. The company's patented technology creates a new class of medical device approved by the FDA for advanced wound management.
- Who founded Amferia?
- Amferia was founded by Anand Kumar Rajasekharan, Saba Atefyekta, Martin Andersson.
- Who are Amferia's investors?
- Amferia's investors include Chalmers Ventures AB, Almi Invest.
- Where is Amferia headquartered?
- Amferia is headquartered in Gothenburg, SE.